Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitalite-DM Tablet ER

Prescription Icon
Prescription Required

Marketer

Griffins Life Sciences Pvt. Ltd

Salt Composition

Dapagliflozin (10mg) + Metformin (500mg) + Sitagliptin (100mg)

Overview Sitalite-DM Tablet ER

Glycemia-Control ER tablets combine medications to manage blood glucose. Used alongside diet and exercise, this medication improves glycemic control in adult type 2 diabetics by enhancing insulin effectiveness, thus reducing blood sugar. Glycemia-Control ER may be taken with or without food, but consistency is key – take it at the same time daily. Dosage is determined by your physician; discontinue only under their guidance, as abrupt cessation can elevate blood sugar, increasing the risk of severe complications including renal impairment and vision loss. This medication complements a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Common side effects include urinary tract infections, nasal congestion, pharyngitis, and upper respiratory infections. Adequate hydration helps prevent dehydration. Genital fungal infections are possible; good hygiene is preventative. Prior to commencing Glycemia-Control ER, disclose any renal or hepatic issues, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should also consult their physician. Limit alcohol consumption as it may exacerbate side effects. Regular blood glucose monitoring is essential while using this medication.

Uses of Sitalite-DM Tablet ER

Managing type 2 diabetes

Major Benefits of Sitalite-DM Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sitalite-DM Extended-Release Tablets can be consumed with or without food; however, consistent daily timing is recommended.

Common Side effects of Sitalite-DM Tablet ER:

  • Diarrhea
  • Nausea
  • Vomiting
  • Flatulence
  • Polyuria
  • Dyslipidemia
  • Genital fungal infection
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Urinary tract infection
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Conjunctivitis
  • Cough

How to use Sitalite-DM Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Sitalite-DM Extended-Release Tablets can be consumed with or without food, however, consistent timing is recommended.

How Sitalite-DM Tablet ER works:

Sitalite-DM Extended-Release tablets contain a triple-action formula to manage diabetes. Dapagliflozin works by enhancing glucose elimination through the urine, thereby lowering blood sugar. Metformin acts on multiple fronts: reducing glucose absorption from food, decreasing liver glucose production, and improving the body's sensitivity to insulin—a hormone regulating blood glucose. Sitagliptin boosts the body's natural insulin-producing mechanisms by stimulating incretin hormones, which promote insulin release from the pancreas and suppress excessive liver glucose output.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Sitalite-DM Tablet ER may pose safety risks; physician consultation is advised.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Sitalite-DM Extended-Release Tablet use in pregnancy is absent. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Sitalite-DM Extended-Release tablets with breastfeeding are currently unavailable. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Sitalite-DM Tablet ER on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Data regarding Sitalite-DM Tablet ER use in individuals with impaired renal function is scarce. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Sitalite-DM Extended-Release Tablets in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Sitalite-DM Tablet ER :

NA

Facts to Know About Sitalite-DM Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Sitalite-DM Tablet ER
160
MRP 195
17% off